A detailed history of Resona Asset Management Co.,Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 53,784 shares of EXAS stock, worth $2.71 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
53,784
Holding current value
$2.71 Million
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$49.33 - $71.97 $2.65 Million - $3.87 Million
53,784 New
53,784 $3.02 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Resona Asset Management Co.,Ltd. Portfolio

Follow Resona Asset Management Co.,Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resona Asset Management Co.,Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Resona Asset Management Co.,Ltd. with notifications on news.